ArticleInternational ophthalmology2026
Orthokeratology for stable mild-to-moderate keratoconus: a pilot study on safety and corneal remodeling via quantitative OCT analysis.
Article in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo assess the efficacy and safety of overnight orthokeratology (Ortho-K) in patients with stable, mild-to-moderate keratoconus and myopia, with a focus on epithelial and Bowman's layer structural changes.
methodsA prospective single-center cohort study enrolled 13 patients (24 eyes) with stable, mild-to-moderate keratoconus (Amsler-Krumeich grades I-II, age 14-21 years) who were fitted with Euclid Emerald Ortho-K lenses and followed for 18 months to evaluate clinical outcomes. Primary outcome measures included uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), refractive error, axial length, corneal topographic parameters, corneal and corneal epithelial thickness (central, nasal, temporal), and quantitative analysis of the cross-sectional area of Bowman's layer using optical coherence tomography (OCT). Treatment-related adverse events and patient dropout were also recorded.
resultsAfter 18 months of intervention, UCVA improved significantly from logMAR 0.59 ± 0.29 to 0.19 ± 0.16 (p < 0.05). The mean myopic refraction significantly decreased from - 2.46 ± 1.25 D to - 0.62 ± 0.24 d (p < 0.05). Characteristic corneal epithelial remodeling was observed: significant thinning in the central zone (from 54 ± 9 to 41 ± 8 μm, p < 0.05) and significant thickening in the nasal and temporal zones (from 51 ± 11 to 64 ± 17 μm and from 62 ± 13 to 71 ± 9 μm, respectively; p < 0.05 for both). The key safety finding was the absence of statistically significant changes in the cross-sectional area of Bowman's layer at the nasal and temporal locations before and after treatment (p > 0.05). Axial length remained stable (mean elongation: 0.14 ± 0.13 mm, p = 0.583). Total higher-order aberrations (HOA) showed a decreasing trend that did not reach statistical significance. Five of the 18 initially enrolled patients discontinued treatment, primarily due to visual symptoms (nocturnal glare, halos) or tolerance issues (dry eye, handling difficulties). A total of 23 episodes of mild corneal punctate staining were recorded, all of which resolved completely following temporary lens discontinuation and pharmacological treatment, with no serious complications.
conclusionIn rigorously selected patients with stable, mild-to-moderate keratoconus, overnight orthokeratology induces predictable epithelial remodeling-characterized by central thinning and paracentral thickening-leading to significant improvements in uncorrected visual acuity and refractive stability. Critically, high-resolution OCT revealed no significant change in the cross-sectional area of Bowman's layer over 18 months, suggesting that this intervention does not compromise deep stromal structural integrity. These findings support orthokeratology as a viable, non-surgical adjunct for daytime spectacle independence in a highly selected ectatic population, provided that stringent fitting protocols and longitudinal structural monitoring are implemented.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.